Porous Silicon Nanodiscs for Targeted Drug Delivery

There is a strong demand for techniques that allow the fabrication of biocompatible porous nanoparticles for drug delivery applications. In this work, a new method to fabricate size‐ and shape‐controlled porous silicon (pSi) nanodiscs is described. The process relies on a combination of colloidal li...

Full description

Saved in:
Bibliographic Details
Published in:Advanced functional materials Vol. 25; no. 7; pp. 1137 - 1145
Main Authors: Alhmoud, Hashim, Delalat, Bahman, Elnathan, Roey, Cifuentes-Rius, Anna, Chaix, Arnaud, Rogers, Mary-Louise, Durand, Jean-Olivier, Voelcker, Nicolas H.
Format: Journal Article
Language:English
Published: Blackwell Publishing Ltd 18-02-2015
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There is a strong demand for techniques that allow the fabrication of biocompatible porous nanoparticles for drug delivery applications. In this work, a new method to fabricate size‐ and shape‐controlled porous silicon (pSi) nanodiscs is described. The process relies on a combination of colloidal lithography and metal‐assisted chemical etching. Height and diameter of the pSi nanodiscs can be easily adjusted. The nanodiscs are degradable in physiological milieu and are nontoxic to mammalian cells. In order to highlight the potential of the pSi nanodiscs in drug delivery, an in vitro investigation that involved loading of nanodiscs with the anticancer agent camptothecin and functionalization of the nanodisc periphery with an antibody that targets receptors on the surface of neuroblastoma cells is carried out. The thus‐prepared nanocarriers are found to selectively attach to and kill cancer cells. The fabrication of disc‐shaped porous silicon nanoparticles through nanosphere lithography and metal‐assisted chemical etching is described. The presented method provides a facile approach to controlling the shape and size of the resulting porous silicon nanoparticles. The targeted delivery of an anticancer drug to cancer cells is undertaken to demonstrate the potential of these particles as drug nanocarriers.
Bibliography:istex:C5FEBC756C7E3B493CA7117352D6C06743F5CF5A
ArticleID:ADFM201403414
ark:/67375/WNG-7HGDG1H3-6
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1616-301X
1616-3028
DOI:10.1002/adfm.201403414